African Pharmaceuticals Market, Forecast to 2020

Assessing Market Potential with a Focus on Kenya and Nigeria

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases.
The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period. The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.


Africa is in a transition phase, on its way to achieving adherence to global standards, such as the WHO pre-qualification for manufacturing. Local production is regarded as a key strategy for sustained access to quality-assured medicines for the long term. The regulatory environment for manufacturing in regions such as East Africa seems to grow rapidly, owing to regional harmonisation. Healthcare coverage is expected to expand to a greater proportion of the population through National Health Insurance (NHI) initiatives, as well as through memberships with private health insurance providers, particularly among the emerging middle class.

South Africa remains as the best established region for pharmaceutical manufacturing in sub-Saharan Africa. However, the local manufacturing markets in East and West Africa are relatively well developed and positioned to grow. A bulk of Africa-based pharmaceutical companies that are developing medicines have simple formulations and mixtures, which are easy to do. Technology transfer is paramount to developing the manufacturing sector in Africa, particularly as the disease burden is changing. There is a paradigm shift coming from the lower end to the higher end of adoption of complex formulations, in line with treatment guidelines, especially in HIV and AIDS and NCDs.

This research service presents findings on 2 fast-growing pharmaceutical markets in sub-Saharan Africa: Kenya and Nigeria. A brief competitive overview, along with the pricing and regulatory environment is provided for each country. Revenues and growth forecasts, insights on market dynamics, and drivers and restraints for the pharmaceutical markets of Kenya and Nigeria are covered. Market segmentation is done based on products (prescription—branded and generic and consumer care/over the counter) as well as therapeutic areas (haematology, oncology, men's health, central nervous system (CNS), women's health, diabetes, cardiovascular, dermatological, gastrointestinal, cough and cold, nutritional, analgesics, and anti-infectives).The study also provides the business opportunities and strategic recommendations for the pharmaceuticals market.

Table of Contents

1. Executive Summary
Market Themes
Key Findings
2. Market Overview
Overview
Key Products and Segments
Impact of Healthcare Industry Mega Trends on the SSA Pharmaceuticals Market
Pharmaceutical Imports
Revenue Forecast
Key Challenges in African Pharmaceuticals Manufacturing
Key Challenges in African Pharmaceuticals Supply Chain
3. Market Analysis—Nigeria
Market Overview
Market Segmentation—Prescription Vs OTC
Market Segmentation and Size—Generic Vs Branded
Prescription Market—Revenue Breakdown by Therapeutic Segments
Prescription Market—Percent Revenue Breakdown by Products
OTC Market—Revenue Breakdown by Therapeutic Segments
Purchasing and Procurement
Pharmaceuticals Market Trends
Market Drivers
Market Restraints
Pricing Analysis
Regulatory Environment
Pharmaceuticals Market—List of Key Participants
Nigeria—Competitive Factors and Assessment
4. Market Analysis—Kenya
Market Overview
Market Segmentation—Prescription Vs OTC
Market Segmentation and Size—Generic Vs Branded
Prescription Market—Revenue Breakdown by Therapeutic Segments
Prescription Market—Percent Revenue Breakdown by Products
OTC Market—Revenue Breakdown by Therapeutic Segments
Purchasing and Procurement
Pharmaceuticals Market Trends
Market Drivers
Market Restraints
Pricing Analysis
Regulatory Environment
Pharmaceuticals Market—List of Key Participants
Kenya—Competitive Factors and Assessment
5. Conclusions and Recommendations
Key Areas of Focus for Pharmaceutical Portfolio
Pharmaceutical Manufacturing
Conclusions and Recommendations
6. The Last Word
The Last Word—3 Big Predictions
The Last Word—Discussion
Legal Disclaimer
7. Market Engineering Methodology

Infographic



List of Figures & Charts

1. Total Pharmaceuticals Market: Products and Segment Definitions, Africa, 2015
2. Pharmaceuticals Market: Variables Impacting the Market, Nigeria, 2015
3. Pharmaceuticals Market: Key Market Drivers, Nigeria, 2016–2020
4. Pharmaceuticals Market: Key Market Restraints, Nigeria, 2016–2020
5. Pharmaceuticals Market: Pricing Analysis, Nigeria, 2015
6. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Nigeria, 2015
7. Pharmaceuticals Market: List of Key Generic Participants, Nigeria, 2015
8. Pharmaceuticals Market: List of Key Branded Participants, Nigeria, 2015
9. Pharmaceuticals Market: Variables Impacting the Market, Kenya, 2015
10. Pharmaceuticals Market: Key Market Drivers, Kenya, 2016–2020
11. Pharmaceuticals Market: Key Market Restraints, Kenya, 2016–2020
12. Pharmaceuticals Market: Pricing Analysis, Kenya, 2015
13. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Kenya, 2015
14. Pharmaceuticals Market: List of Key Generic Participants, Kenya, 2015
15. Pharmaceuticals Market: List of Key Branded Participants, Kenya, 2015
16. Key Areas of Focus Within Prescription Drugs Market, Nigeria and Kenya, 2015
17. Key Areas of Focus Within OTC Products Market, Nigeria and Kenya, 2015


1. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2010
2. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2030
3. Total Pharmaceuticals Market: Pharmaceutical Spending, Africa, 2014–2020
4. Total Pharmaceuticals Market: Imports—Percent Share by Type, Sub-Saharan Africa, 2014
5. Total Pharmaceuticals Market: Imports—Percent Share by Country, Sub-Saharan Africa, 2014
6. Total Pharmaceuticals Market: Revenue Forecast, Africa*, 2015–2020
7. Prescription Market: Revenue Breakdown by Products, Nigeria, 2015
8. Prescription Market: Percent Revenue Breakdown by Product Segments, Nigeria, 2015
9. Prescription Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015
10. Prescription Market: Percent Revenue Breakdown by Products, Nigeria, 2015
11. OTC Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015
12. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Nigeria, 2015
13. Pharmaceuticals Market: Revenue Breakdown by Segments, Kenya, 2015
14. Prescription Market: Revenue Breakdown by Products, Kenya, 2015
15. Prescription Market: Percent Revenue Breakdown by Product Segments, Kenya, 2015
16. Prescription Market: Revenue Breakdown by Therapeutic Segments, Kenya, 2015
17. Prescription Market: Percent Revenue Breakdown by Products, Kenya, 2015
18. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Kenya, 2015
19. Pharmaceuticals Market: Percent Breakdown by Segments, Nigeria and Kenya, 2015
20.


Related Research

Release Date : 27-Sep-17

Region : Africa

Release Date : 27-May-2016

Region : Africa

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.